Lv1
85 积分 2022-03-25 加入
Mitigation of therapeutic anti‐CD38 antibody interference with fab fragments: How well does it perform?
6个月前
已完结
F(ab′) 2 Fragments to Overcome Daratumumab Interference in Transfusion Tests
6个月前
已完结
F(ab′) 2 Fragments to Overcome Daratumumab Interference in Transfusion Tests
6个月前
已完结
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
6个月前
已完结
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
6个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab
7个月前
已完结
皖公网安备34019202002308
